schliessen

Filtern

 

Bibliotheken

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Background: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, w... Full description

Journal Title: The Lancet 392 (10159) pp. 1923-1994. (2018)
Main Author: Stanaway, Jd
Other Authors: Afshin, A , Gakidou, E , Lim, Ss , Abate, D , Abate, Kh , Abbafati, C , Abbasi, N , Abbastabar, H , Abd - Allah, F , Abdela, J , Abdelalim, A , Abdollahpour, I , Abdulkader, Rs , Abebe, M , Abebe, Z , Abera, Sf , Abil, Oz , Abraha, Hn , Abrham, Ar , Abu - Raddad, Lj , Abu - Rmeileh, Nme , Accrombessi, Mmk , Acharya, D , Acharya, P , Adamu, Aa , Adane, Aa , Adebayo, Om , Adedoyin, Ra , Adekanmbi, V , Ademi, Z , Adetokunboh, O , Adib, Mg , Admasie, A , Adsuar, Jc , Afanvi, Ka , Afarideh, M , Agarwal, G , Aggarwal, A , Aghayan, Sa , Agrawal, A , Agrawal, S , Ahmadi, A , Ahmadi, M , Ahmadieh, H , Ahmed, Mb , Aichour, An , Aichour, I , Aichour, Mte , Akbari, Me , Akinyemiju, T , Akseer, N , Al - Aly, Z , Al - Eyadhy, A , Al - Mekhlafi, Hm , Alandab, F , Alam, K , Alam, S , Alam, T , Alashi, A , Alavian, Sm , Alene, Ka , Ali, K , Ali, Sm , Alijanzadeh, M , Alizadeh - Navaei, R , Aljunid, Sm , Alkerwi, A , Alla, F , Alsharif, U , Altirkawi, K , Alvis - Guzman, N , Amare, At , Ammar, W , Anber, Nh , Anderson, Ja , Andrei, Cl , Androudi, S , Animut, Md , Anjomshoa, M , Ansha, Mg , Anto, Jm , Antonio, Cat , Anwari, P , Appiah, Lt , Appiah, Scy , Arabloo, J , Aremu, O , Amlov, J , Artaman, A , Aryal, Kk , Asayesh, H , Ataro, Z , Ausloos, M , Avokpaho, Efga , Awasthi, A , Quintanilla, Bpa , Ayer, R , Ayuk, Tb , Azzopardi, Ps , Babazadeff, A , Badali, H , Badawi, A , Balakrishnan, K , Bali, Ag , Ball, K , Bellew, Sh , Banach, M , Banoub, Jam , Barac, A , Barker - Collo, Sl , Bamighausen, Tw , Barrero, Lh , Basu, S , Baune, Bt , Bazargan - Hejazi, S , Bedi, N , Beghi, E , Behzadifar, M , Behzadifar, M , Bejoy, Y , Bekele, Bb , Bekru, Ft , Belay, E , Belay, Ya , Bell, Ml , Bello, Ak , Bennett, Da , Bensenor, Im , Bergeron, G , Berhane, A , Bemabe, E , Bemstein, Rs , Beuran, M , Beyranvand, T , Bhala, N , Bhalla, A , Bhattarai, S , Bhutta, Za , Biadgo, B , Bijani, A , Bikbov, B , Bilano, V , Bililign, N , Bin Sayeed, Ms , Bisanzio, D , Biswas, T , Bjorge, T , Blacker, Bf , Bleyer, A , Borschmann, R , Bou - Orm, Ir , Boufous, S , Bourne, R , Brady, Oj , Brauer, M , Brazinova, A , Breitborde, Njk , Brenner, H , Briko, An , Britton, G , Brugha, T , Buchbindet, R , Burnett, Rt , Busse, R , Butt, Za , Cahill, Le , Cahuana - Hurtado, L , Campos - Nonato, Ir , Cardenas, R , Carreras, G , Carrero, Jj , Carvalho, F , Castaneda - Orjuela, Ca , Rivas, Jc , Castro, F , Catala - Lopez, F , Causey, K , Cercy, Km , Cerin, E , Chaiah, Y , Chang, H - T , Chang, J - C , Chang, K - L , Charlson, Fj , Chattopadhyay, A , Chattu, Vk , Chee, Ml , Cheng, C - Y , Chew, A , Chiang, Pp - C , Chimed - Ochir, O , Chin, Kl , Chitheer, A , Choi, J - Yj , Chowdhury, R , Christensen, H , Christopher, Dj , Chung, S - C , Cicuttini, Fm , Grillo, M , Cohen, Aj , Collado - Mateo, D , Cooper, C , Cooper, Or , Coresh, J , Cornaby, L , Cortesi, Pa , Cortinovis, M , Costa, M , Cousin, E , Criqui, Mh , Cromwell, Ea , Cundiff, Dk , Daba, Ak , Dachew, Ba , Dadi, Af , Damasceno, Aam , Dandona, L , Dandona, R , Darby, Sc , Dargan, Pi , Daryani, A , Das Gupta, R , Das Neves, J , Dasa, Tt , Dash, Ap , Davitoiu, Dv , Davletov, K , De La Cruz - Gongora, V , De La Hoz, Fp , De Leo, D , De Neve, J - W , Degenhardt, L , Deiparine, S , Dellavalle, Rp , Demoz, Gt , Denova - Gutierrez, E , Deribe, K , Dervenis, N , Deshpande, A , Jarlais, Dcd , Dessie, Ga , Deveber, Ga , Dey, S , Dharmaratne, Sd , Dhimal, M , Dinberu, Mt , Ding, El , Diro, Hd
Format: Electronic Article Electronic Article
Language: English
Quelle: University College London (UCL)
Created: 2018
Link: http://discovery.ucl.ac.uk/10063523/
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: ucl10063523
title: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
format: Article
creator:
  • Stanaway, Jd
  • Afshin, A
  • Gakidou, E
  • Lim, Ss
  • Abate, D
  • Abate, Kh
  • Abbafati, C
  • Abbasi, N
  • Abbastabar, H
  • Abd - Allah, F
  • Abdela, J
  • Abdelalim, A
  • Abdollahpour, I
  • Abdulkader, Rs
  • Abebe, M
  • Abebe, Z
  • Abera, Sf
  • Abil, Oz
  • Abraha, Hn
  • Abrham, Ar
  • Abu - Raddad, Lj
  • Abu - Rmeileh, Nme
  • Accrombessi, Mmk
  • Acharya, D
  • Acharya, P
  • Adamu, Aa
  • Adane, Aa
  • Adebayo, Om
  • Adedoyin, Ra
  • Adekanmbi, V
  • Ademi, Z
  • Adetokunboh, O
  • Adib, Mg
  • Admasie, A
  • Adsuar, Jc
  • Afanvi, Ka
  • Afarideh, M
  • Agarwal, G
  • Aggarwal, A
  • Aghayan, Sa
  • Agrawal, A
  • Agrawal, S
  • Ahmadi, A
  • Ahmadi, M
  • Ahmadieh, H
  • Ahmed, Mb
  • Aichour, An
  • Aichour, I
  • Aichour, Mte
  • Akbari, Me
  • Akinyemiju, T
  • Akseer, N
  • Al - Aly, Z
  • Al - Eyadhy, A
  • Al - Mekhlafi, Hm
  • Alandab, F
  • Alam, K
  • Alam, S
  • Alam, T
  • Alashi, A
  • Alavian, Sm
  • Alene, Ka
  • Ali, K
  • Ali, Sm
  • Alijanzadeh, M
  • Alizadeh - Navaei, R
  • Aljunid, Sm
  • Alkerwi, A
  • Alla, F
  • Alsharif, U
  • Altirkawi, K
  • Alvis - Guzman, N
  • Amare, At
  • Ammar, W
  • Anber, Nh
  • Anderson, Ja
  • Andrei, Cl
  • Androudi, S
  • Animut, Md
  • Anjomshoa, M
  • Ansha, Mg
  • Anto, Jm
  • Antonio, Cat
  • Anwari, P
  • Appiah, Lt
  • Appiah, Scy
  • Arabloo, J
  • Aremu, O
  • Amlov, J
  • Artaman, A
  • Aryal, Kk
  • Asayesh, H
  • Ataro, Z
  • Ausloos, M
  • Avokpaho, Efga
  • Awasthi, A
  • Quintanilla, Bpa
  • Ayer, R
  • Ayuk, Tb
  • Azzopardi, Ps
  • Babazadeff, A
  • Badali, H
  • Badawi, A
  • Balakrishnan, K
  • Bali, Ag
  • Ball, K
  • Bellew, Sh
  • Banach, M
  • Banoub, Jam
  • Barac, A
  • Barker - Collo, Sl
  • Bamighausen, Tw
  • Barrero, Lh
  • Basu, S
  • Baune, Bt
  • Bazargan - Hejazi, S
  • Bedi, N
  • Beghi, E
  • Behzadifar, M
  • Behzadifar, M
  • Bejoy, Y
  • Bekele, Bb
  • Bekru, Ft
  • Belay, E
  • Belay, Ya
  • Bell, Ml
  • Bello, Ak
  • Bennett, Da
  • Bensenor, Im
  • Bergeron, G
  • Berhane, A
  • Bemabe, E
  • Bemstein, Rs
  • Beuran, M
  • Beyranvand, T
  • Bhala, N
  • Bhalla, A
  • Bhattarai, S
  • Bhutta, Za
  • Biadgo, B
  • Bijani, A
  • Bikbov, B
  • Bilano, V
  • Bililign, N
  • Bin Sayeed, Ms
  • Bisanzio, D
  • Biswas, T
  • Bjorge, T
  • Blacker, Bf
  • Bleyer, A
  • Borschmann, R
  • Bou - Orm, Ir
  • Boufous, S
  • Bourne, R
  • Brady, Oj
  • Brauer, M
  • Brazinova, A
  • Breitborde, Njk
  • Brenner, H
  • Briko, An
  • Britton, G
  • Brugha, T
  • Buchbindet, R
  • Burnett, Rt
  • Busse, R
  • Butt, Za
  • Cahill, Le
  • Cahuana - Hurtado, L
  • Campos - Nonato, Ir
  • Cardenas, R
  • Carreras, G
  • Carrero, Jj
  • Carvalho, F
  • Castaneda - Orjuela, Ca
  • Rivas, Jc
  • Castro, F
  • Catala - Lopez, F
  • Causey, K
  • Cercy, Km
  • Cerin, E
  • Chaiah, Y
  • Chang, H - T
  • Chang, J - C
  • Chang, K - L
  • Charlson, Fj
  • Chattopadhyay, A
  • Chattu, Vk
  • Chee, Ml
  • Cheng, C - Y
  • Chew, A
  • Chiang, Pp - C
  • Chimed - Ochir, O
  • Chin, Kl
  • Chitheer, A
  • Choi, J - Yj
  • Chowdhury, R
  • Christensen, H
  • Christopher, Dj
  • Chung, S - C
  • Cicuttini, Fm
  • Grillo, M
  • Cohen, Aj
  • Collado - Mateo, D
  • Cooper, C
  • Cooper, Or
  • Coresh, J
  • Cornaby, L
  • Cortesi, Pa
  • Cortinovis, M
  • Costa, M
  • Cousin, E
  • Criqui, Mh
  • Cromwell, Ea
  • Cundiff, Dk
  • Daba, Ak
  • Dachew, Ba
  • Dadi, Af
  • Damasceno, Aam
  • Dandona, L
  • Dandona, R
  • Darby, Sc
  • Dargan, Pi
  • Daryani, A
  • Das Gupta, R
  • Das Neves, J
  • Dasa, Tt
  • Dash, Ap
  • Davitoiu, Dv
  • Davletov, K
  • De La Cruz - Gongora, V
  • De La Hoz, Fp
  • De Leo, D
  • De Neve, J - W
  • Degenhardt, L
  • Deiparine, S
  • Dellavalle, Rp
  • Demoz, Gt
  • Denova - Gutierrez, E
  • Deribe, K
  • Dervenis, N
  • Deshpande, A
  • Jarlais, Dcd
  • Dessie, Ga
  • Deveber, Ga
  • Dey, S
  • Dharmaratne, Sd
  • Dhimal, M
  • Dinberu, Mt
  • Ding, El
  • Diro, Hd
ispartof: The Lancet , 392 (10159) pp. 1923-1994. (2018)
description: Background: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associations. Methods: We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk–outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the risk-deleted death and DALY rates, where the risk-deleted rate is the rate that would be observed had we reduced the exposure levels to the TMREL for all risk factors included in GBD 2017. Findings: In 2017, 34·1 million (95% uncertainty interval [UI] 33·3–35·0) deaths and 1·21 billion (1·14–1·28) DALYs were attributable to GBD risk factors. Globally, 61·0% (59·6–62·4) of deaths and 48·3% (46·3–50·2) of DALYs were attributed to the GBD 2017 risk fact
language: eng
source: University College London (UCL)
identifier:
fulltext: fulltext_linktorsrc
url: Link


@attributes
ID1577101385
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10063523
sourceiducl
recordidTN_ucl10063523
sourcesystemPC
display
typearticle
titleGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
creatorStanaway, Jd ; Afshin, A ; Gakidou, E ; Lim, Ss ; Abate, D ; Abate, Kh ; Abbafati, C ; Abbasi, N ; Abbastabar, H ; Abd - Allah, F ; Abdela, J ; Abdelalim, A ; Abdollahpour, I ; Abdulkader, Rs ; Abebe, M ; Abebe, Z ; Abera, Sf ; Abil, Oz ; Abraha, Hn ; Abrham, Ar ; Abu - Raddad, Lj ; Abu - Rmeileh, Nme ; Accrombessi, Mmk ; Acharya, D ; Acharya, P ; Adamu, Aa ; Adane, Aa ; Adebayo, Om ; Adedoyin, Ra ; Adekanmbi, V ; Ademi, Z ; Adetokunboh, O ; Adib, Mg ; Admasie, A ; Adsuar, Jc ; Afanvi, Ka ; Afarideh, M ; Agarwal, G ; Aggarwal, A ; Aghayan, Sa ; Agrawal, A ; Agrawal, S ; Ahmadi, A ; Ahmadi, M ; Ahmadieh, H ; Ahmed, Mb ; Aichour, An ; Aichour, I ; Aichour, Mte ; Akbari, Me ; Akinyemiju, T ; Akseer, N ; Al - Aly, Z ; Al - Eyadhy, A ; Al - Mekhlafi, Hm ; Alandab, F ; Alam, K ; Alam, S ; Alam, T ; Alashi, A ; Alavian, Sm ; Alene, Ka ; Ali, K ; Ali, Sm ; Alijanzadeh, M ; Alizadeh - Navaei, R ; Aljunid, Sm ; Alkerwi, A ; Alla, F ; Alsharif, U ; Altirkawi, K ; Alvis - Guzman, N ; Amare, At ; Ammar, W ; Anber, Nh ; Anderson, Ja ; Andrei, Cl ; Androudi, S ; Animut, Md ; Anjomshoa, M ; Ansha, Mg ; Anto, Jm ; Antonio, Cat ; Anwari, P ; Appiah, Lt ; Appiah, Scy ; Arabloo, J ; Aremu, O ; Amlov, J ; Artaman, A ; Aryal, Kk ; Asayesh, H ; Ataro, Z ; Ausloos, M ; Avokpaho, Efga ; Awasthi, A ; Quintanilla, Bpa ; Ayer, R ; Ayuk, Tb ; Azzopardi, Ps ; Babazadeff, A ; Badali, H ; Badawi, A ; Balakrishnan, K ; Bali, Ag ; Ball, K ; Bellew, Sh ; Banach, M ; Banoub, Jam ; Barac, A ; Barker - Collo, Sl ; Bamighausen, Tw ; Barrero, Lh ; Basu, S ; Baune, Bt ; Bazargan - Hejazi, S ; Bedi, N ; Beghi, E ; Behzadifar, M ; Behzadifar, M ; Bejoy, Y ; Bekele, Bb ; Bekru, Ft ; Belay, E ; Belay, Ya ; Bell, Ml ; Bello, Ak ; Bennett, Da ; Bensenor, Im ; Bergeron, G ; Berhane, A ; Bemabe, E ; Bemstein, Rs ; Beuran, M ; Beyranvand, T ; Bhala, N ; Bhalla, A ; Bhattarai, S ; Bhutta, Za ; Biadgo, B ; Bijani, A ; Bikbov, B ; Bilano, V ; Bililign, N ; Bin Sayeed, Ms ; Bisanzio, D ; Biswas, T ; Bjorge, T ; Blacker, Bf ; Bleyer, A ; Borschmann, R ; Bou - Orm, Ir ; Boufous, S ; Bourne, R ; Brady, Oj ; Brauer, M ; Brazinova, A ; Breitborde, Njk ; Brenner, H ; Briko, An ; Britton, G ; Brugha, T ; Buchbindet, R ; Burnett, Rt ; Busse, R ; Butt, Za ; Cahill, Le ; Cahuana - Hurtado, L ; Campos - Nonato, Ir ; Cardenas, R ; Carreras, G ; Carrero, Jj ; Carvalho, F ; Castaneda - Orjuela, Ca ; Rivas, Jc ; Castro, F ; Catala - Lopez, F ; Causey, K ; Cercy, Km ; Cerin, E ; Chaiah, Y ; Chang, H - T ; Chang, J - C ; Chang, K - L ; Charlson, Fj ; Chattopadhyay, A ; Chattu, Vk ; Chee, Ml ; Cheng, C - Y ; Chew, A ; Chiang, Pp - C ; Chimed - Ochir, O ; Chin, Kl ; Chitheer, A ; Choi, J - Yj ; Chowdhury, R ; Christensen, H ; Christopher, Dj ; Chung, S - C ; Cicuttini, Fm ; Grillo, M ; Cohen, Aj ; Collado - Mateo, D ; Cooper, C ; Cooper, Or ; Coresh, J ; Cornaby, L ; Cortesi, Pa ; Cortinovis, M ; Costa, M ; Cousin, E ; Criqui, Mh ; Cromwell, Ea ; Cundiff, Dk ; Daba, Ak ; Dachew, Ba ; Dadi, Af ; Damasceno, Aam ; Dandona, L ; Dandona, R ; Darby, Sc ; Dargan, Pi ; Daryani, A ; Das Gupta, R ; Das Neves, J ; Dasa, Tt ; Dash, Ap ; Davitoiu, Dv ; Davletov, K ; De La Cruz - Gongora, V ; De La Hoz, Fp ; De Leo, D ; De Neve, J - W ; Degenhardt, L ; Deiparine, S ; Dellavalle, Rp ; Demoz, Gt ; Denova - Gutierrez, E ; Deribe, K ; Dervenis, N ; Deshpande, A ; Jarlais, Dcd ; Dessie, Ga ; Deveber, Ga ; Dey, S ; Dharmaratne, Sd ; Dhimal, M ; Dinberu, Mt ; Ding, El ; Diro, Hd
creationdate2018
ispartofThe Lancet , 392 (10159) pp. 1923-1994. (2018)
descriptionBackground: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associations. Methods: We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk–outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the risk-deleted death and DALY rates, where the risk-deleted rate is the rate that would be observed had we reduced the exposure levels to the TMREL for all risk factors included in GBD 2017. Findings: In 2017, 34·1 million (95% uncertainty interval [UI] 33·3–35·0) deaths and 1·21 billion (1·14–1·28) DALYs were attributable to GBD risk factors. Globally, 61·0% (59·6–62·4) of deaths and 48·3% (46·3–50·2) of DALYs were attributed to the GBD 2017 risk factors. When ranked by risk-attributable DALYs, high systolic blood pressure (SBP) was the leading risk factor, accounting for 10·4 million (9·39–11·5) deaths and 218 million (198–237) DALYs, followed by smoking (7·10 million [6·83–7·37] deaths and 182 million [173–193] DALYs), high fasting plasma glucose (6·53 million [5·23–8·23] deaths and 171 million [144–201] DALYs), high body-mass index (BMI; 4·72 million [2·99–6·70] deaths and 148 million [98·6–202] DALYs), and short gestation for birthweight (1·43 million [1·36–1·51] deaths and 139 million [131–147] DALYs). In total, risk-attributable DALYs declined by 4·9% (3·3–6·5) between 2007 and 2017. In the absence of demographic changes (ie, population growth and ageing), changes in risk exposure and risk-deleted DALYs would have led to a 23·5% decline in DALYs during that period. Conversely, in the absence of changes in risk exposure and risk-deleted DALYs, demographic changes would have led to an 18·6% increase in DALYs during that period. The ratios of observed risk exposure levels to exposure levels expected based on SDI (O/E ratios) increased globally for unsafe drinking water and household air pollution between 1990 and 2017. This result suggests that development is occurring more rapidly than are changes in the underlying risk structure in a population. Conversely, nearly universal declines in O/E ratios for smoking and alcohol use indicate that, for a given SDI, exposure to these risks is declining. In 2017, the leading Level 4 risk factor for age-standardised DALY rates was high SBP in four super-regions: central Europe, eastern Europe, and central Asia; north Africa and Middle East; south Asia; and southeast Asia, east Asia, and Oceania. The leading risk factor in the high-income super-region was smoking, in Latin America and Caribbean was high BMI, and in sub-Saharan Africa was unsafe sex. O/E ratios for unsafe sex in sub-Saharan Africa were notably high, and those for alcohol use in north Africa and the Middle East were notably low. Interpretation: By quantifying levels and trends in exposures to risk factors and the resulting disease burden, this assessment offers insight into where past policy and programme efforts might have been successful and highlights current priorities for public health action. Decreases in behavioural, environmental, and occupational risks have largely offset the effects of population growth and ageing, in relation to trends in absolute burden. Conversely, the combination of increasing metabolic risks and population ageing will probably continue to drive the increasing trends in non-communicable diseases at the global level, which presents both a public health challenge and opportunity. We see considerable spatiotemporal heterogeneity in levels of risk exposure and risk-attributable burden. Although levels of development underlie some of this heterogeneity, O/E ratios show risks for which countries are overperforming or underperforming relative to their level of development. As such, these ratios provide a benchmarking tool to help to focus local decision making. Our findings reinforce the importance of both risk exposure monitoring and epidemiological research to assess causal connections between risks and health outcomes, and they highlight the usefulness of the GBD study in synthesising data to draw comprehensive and robust conclusions that help to inform good policy and strategic health planning.
languageeng
sourceUniversity College London (UCL)
oafree_for_read
links
openurl$$Topenurl_article
backlink$$Uhttp://discovery.ucl.ac.uk/10063523/$$EView_this_record_in_University_College_London_(UCL)
linktorsrc$$Uhttp://discovery.ucl.ac.uk/10063523/1/Global%20Burden%20of%20Disease%20_s2.0-S0140673618322256-main.pdf$$EView_full_text_in_University_College_London_(UCL)
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Stanaway, Jd
1Afshin, A
2Gakidou, E
3Lim, Ss
4Abate, D
5Abate, Kh
6Abbafati, C
7Abbasi, N
8Abbastabar, H
9Abd - Allah, F
10Abdela, J
11Abdelalim, A
12Abdollahpour, I
13Abdulkader, Rs
14Abebe, M
15Abebe, Z
16Abera, Sf
17Abil, Oz
18Abraha, Hn
19Abrham, Ar
20Abu - Raddad, Lj
21Abu - Rmeileh, Nme
22Accrombessi, Mmk
23Acharya, D
24Acharya, P
25Adamu, Aa
26Adane, Aa
27Adebayo, Om
28Adedoyin, Ra
29Adekanmbi, V
30Ademi, Z
31Adetokunboh, O
32Adib, Mg
33Admasie, A
34Adsuar, Jc
35Afanvi, Ka
36Afarideh, M
37Agarwal, G
38Aggarwal, A
39Aghayan, Sa
40Agrawal, A
41Agrawal, S
42Ahmadi, A
43Ahmadi, M
44Ahmadieh, H
45Ahmed, Mb
46Aichour, An
47Aichour, I
48Aichour, Mte
49Akbari, Me
50Akinyemiju, T
51Akseer, N
52Al - Aly, Z
53Al - Eyadhy, A
54Al - Mekhlafi, Hm
55Alandab, F
56Alam, K
57Alam, S
58Alam, T
59Alashi, A
60Alavian, Sm
61Alene, Ka
62Ali, K
63Ali, Sm
64Alijanzadeh, M
65Alizadeh - Navaei, R
66Aljunid, Sm
67Alkerwi, A
68Alla, F
69Alsharif, U
70Altirkawi, K
71Alvis - Guzman, N
72Amare, At
73Ammar, W
74Anber, Nh
75Anderson, Ja
76Andrei, Cl
77Androudi, S
78Animut, Md
79Anjomshoa, M
80Ansha, Mg
81Anto, Jm
82Antonio, Cat
83Anwari, P
84Appiah, Lt
85Appiah, Scy
86Arabloo, J
87Aremu, O
88Amlov, J
89Artaman, A
90Aryal, Kk
91Asayesh, H
92Ataro, Z
93Ausloos, M
94Avokpaho, Efga
95Awasthi, A
96Quintanilla, Bpa
97Ayer, R
98Ayuk, Tb
99Azzopardi, Ps
100...
titleGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
descriptionBackground: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associations. Methods: We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk–outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the risk-deleted death and DALY rates, where the risk-deleted rate is the rate that would be observed had we reduced the exposure levels to the TMREL for all risk factors included in GBD 2017. Findings: In 2017, 34·1 million (95% uncertainty interval [UI] 33·3–35·0) deaths and 1·21 billion (1·14–1·28) DALYs were attributable to GBD risk factors. Globally, 61·0% (59·6–62·4) of deaths and 48·3% (46·3–50·2) of DALYs were attributed to the GBD 2017 risk factors. When ranked by risk-attributable DALYs, high systolic blood pressure (SBP) was the leading risk factor, accounting for 10·4 million (9·39–11·5) deaths and 218 million (198–237) DALYs, followed by smoking (7·10 million [6·83–7·37] deaths and 182 million [173–193] DALYs), high fasting plasma glucose (6·53 million [5·23–8·23] deaths and 171 million [144–201] DALYs), high body-mass index (BMI; 4·72 million [2·99–6·70] deaths and 148 million [98·6–202] DALYs), and short gestation for birthweight (1·43 million [1·36–1·51] deaths and 139 million [131–147] DALYs). In total, risk-attributable DALYs declined by 4·9% (3·3–6·5) between 2007 and 2017. In the absence of demographic changes (ie, population growth and ageing), changes in risk exposure and risk-deleted DALYs would have led to a 23·5% decline in DALYs during that period. Conversely, in the absence of changes in risk exposure and risk-deleted DALYs, demographic changes would have led to an 18·6% increase in DALYs during that period. The ratios of observed risk exposure levels to exposure levels expected based on SDI (O/E ratios) increased globally for unsafe drinking water and household air pollution between 1990 and 2017. This result suggests that development is occurring more rapidly than are changes in the underlying risk structure in a population. Conversely, nearly universal declines in O/E ratios for smoking and alcohol use indicate that, for a given SDI, exposure to these risks is declining. In 2017, the leading Level 4 risk factor for age-standardised DALY rates was high SBP in four super-regions: central Europe, eastern Europe, and central Asia; north Africa and Middle East; south Asia; and southeast Asia, east Asia, and Oceania. The leading risk factor in the high-income super-region was smoking, in Latin America and Caribbean was high BMI, and in sub-Saharan Africa was unsafe sex. O/E ratios for unsafe sex in sub-Saharan Africa were notably high, and those for alcohol use in north Africa and the Middle East were notably low. Interpretation: By quantifying levels and trends in exposures to risk factors and the resulting disease burden, this assessment offers insight into where past policy and programme efforts might have been successful and highlights current priorities for public health action. Decreases in behavioural, environmental, and occupational risks have largely offset the effects of population growth and ageing, in relation to trends in absolute burden. Conversely, the combination of increasing metabolic risks and population ageing will probably continue to drive the increasing trends in non-communicable diseases at the global level, which presents both a public health challenge and opportunity. We see considerable spatiotemporal heterogeneity in levels of risk exposure and risk-attributable burden. Although levels of development underlie some of this heterogeneity, O/E ratios show risks for which countries are overperforming or underperforming relative to their level of development. As such, these ratios provide a benchmarking tool to help to focus local decision making. Our findings reinforce the importance of both risk exposure monitoring and epidemiological research to assess causal connections between risks and health outcomes, and they highlight the usefulness of the GBD study in synthesising data to draw comprehensive and robust conclusions that help to inform good policy and strategic health planning.
general
0English
1ELSEVIER SCIENCE INC
2UCL Discovery (University College London)
sourceiducl
recordiducl10063523
rsrctypearticle
creationdate2018
addtitleThe Lancet
searchscopeucl
scopeucl
sort
titleGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
authorStanaway, Jd ; Afshin, A ; Gakidou, E ; Lim, Ss ; Abate, D ; Abate, Kh ; Abbafati, C ; Abbasi, N ; Abbastabar, H ; Abd - Allah, F ; Abdela, J ; Abdelalim, A ; Abdollahpour, I ; Abdulkader, Rs ; Abebe, M ; Abebe, Z ; Abera, Sf ; Abil, Oz ; Abraha, Hn ; Abrham, Ar ; Abu - Raddad, Lj ; Abu - Rmeileh, Nme ; Accrombessi, Mmk ; Acharya, D ; Acharya, P ; Adamu, Aa ; Adane, Aa ; Adebayo, Om ; Adedoyin, Ra ; Adekanmbi, V ; Ademi, Z ; Adetokunboh, O ; Adib, Mg ; Admasie, A ; Adsuar, Jc ; Afanvi, Ka ; Afarideh, M ; Agarwal, G ; Aggarwal, A ; Aghayan, Sa ; Agrawal, A ; Agrawal, S ; Ahmadi, A ; Ahmadi, M ; Ahmadieh, H ; Ahmed, Mb ; Aichour, An ; Aichour, I ; Aichour, Mte ; Akbari, Me ; Akinyemiju, T ; Akseer, N ; Al - Aly, Z ; Al - Eyadhy, A ; Al - Mekhlafi, Hm ; Alandab, F ; Alam, K ; Alam, S ; Alam, T ; Alashi, A ; Alavian, Sm ; Alene, Ka ; Ali, K ; Ali, Sm ; Alijanzadeh, M ; Alizadeh - Navaei, R ; Aljunid, Sm ; Alkerwi, A ; Alla, F ; Alsharif, U ; Altirkawi, K ; Alvis - Guzman, N ; Amare, At ; Ammar, W ; Anber, Nh ; Anderson, Ja ; Andrei, Cl ; Androudi, S ; Animut, Md ; Anjomshoa, M ; Ansha, Mg ; Anto, Jm ; Antonio, Cat ; Anwari, P ; Appiah, Lt ; Appiah, Scy ; Arabloo, J ; Aremu, O ; Amlov, J ; Artaman, A ; Aryal, Kk ; Asayesh, H ; Ataro, Z ; Ausloos, M ; Avokpaho, Efga ; Awasthi, A ; Quintanilla, Bpa ; Ayer, R ; Ayuk, Tb ; Azzopardi, Ps ; Babazadeff, A ; Badali, H ; Badawi, A ; Balakrishnan, K ; Bali, Ag ; Ball, K ; Bellew, Sh ; Banach, M ; Banoub, Jam ; Barac, A ; Barker - Collo, Sl ; Bamighausen, Tw ; Barrero, Lh ; Basu, S ; Baune, Bt ; Bazargan - Hejazi, S ; Bedi, N ; Beghi, E ; Behzadifar, M ; Behzadifar, M ; Bejoy, Y ; Bekele, Bb ; Bekru, Ft ; Belay, E ; Belay, Ya ; Bell, Ml ; Bello, Ak ; Bennett, Da ; Bensenor, Im ; Bergeron, G ; Berhane, A ; Bemabe, E ; Bemstein, Rs ; Beuran, M ; Beyranvand, T ; Bhala, N ; Bhalla, A ; Bhattarai, S ; Bhutta, Za ; Biadgo, B ; Bijani, A ; Bikbov, B ; Bilano, V ; Bililign, N ; Bin Sayeed, Ms ; Bisanzio, D ; Biswas, T ; Bjorge, T ; Blacker, Bf ; Bleyer, A ; Borschmann, R ; Bou - Orm, Ir ; Boufous, S ; Bourne, R ; Brady, Oj ; Brauer, M ; Brazinova, A ; Breitborde, Njk ; Brenner, H ; Briko, An ; Britton, G ; Brugha, T ; Buchbindet, R ; Burnett, Rt ; Busse, R ; Butt, Za ; Cahill, Le ; Cahuana - Hurtado, L ; Campos - Nonato, Ir ; Cardenas, R ; Carreras, G ; Carrero, Jj ; Carvalho, F ; Castaneda - Orjuela, Ca ; Rivas, Jc ; Castro, F ; Catala - Lopez, F ; Causey, K ; Cercy, Km ; Cerin, E ; Chaiah, Y ; Chang, H - T ; Chang, J - C ; Chang, K - L ; Charlson, Fj ; Chattopadhyay, A ; Chattu, Vk ; Chee, Ml ; Cheng, C - Y ; Chew, A ; Chiang, Pp - C ; Chimed - Ochir, O ; Chin, Kl ; Chitheer, A ; Choi, J - Yj ; Chowdhury, R ; Christensen, H ; Christopher, Dj ; Chung, S - C ; Cicuttini, Fm ; Grillo, M ; Cohen, Aj ; Collado - Mateo, D ; Cooper, C ; Cooper, Or ; Coresh, J ; Cornaby, L ; Cortesi, Pa ; Cortinovis, M ; Costa, M ; Cousin, E ; Criqui, Mh ; Cromwell, Ea ; Cundiff, Dk ; Daba, Ak ; Dachew, Ba ; Dadi, Af ; Damasceno, Aam ; Dandona, L ; Dandona, R ; Darby, Sc ; Dargan, Pi ; Daryani, A ; Das Gupta, R ; Das Neves, J ; Dasa, Tt ; Dash, Ap ; Davitoiu, Dv ; Davletov, K ; De La Cruz - Gongora, V ; De La Hoz, Fp ; De Leo, D ; De Neve, J - W ; Degenhardt, L ; Deiparine, S ; Dellavalle, Rp ; Demoz, Gt ; Denova - Gutierrez, E ; Deribe, K ; Dervenis, N ; Deshpande, A ; Jarlais, Dcd ; Dessie, Ga ; Deveber, Ga ; Dey, S ; Dharmaratne, Sd ; Dhimal, M ; Dinberu, Mt ; Ding, El ; Diro, Hd
creationdate20181110
facets
frbrgroupid6131124193389645510
frbrtype6
newrecords20190227
languageeng
creationdate2018
collectionUCL Discovery (University College London)
prefilterarticles
rsrctypearticles
creatorcontrib
0Stanaway, Jd
1Afshin, A
2Gakidou, E
3Lim, Ss
4Abate, D
5Abate, Kh
6Abbafati, C
7Abbasi, N
8Abbastabar, H
9Abd - Allah, F
10Abdela, J
11Abdelalim, A
12Abdollahpour, I
13Abdulkader, Rs
14Abebe, M
15Abebe, Z
16Abera, Sf
17Abil, Oz
18Abraha, Hn
19Abrham, Ar
20Abu - Raddad, Lj
21Abu - Rmeileh, Nme
22Accrombessi, Mmk
23Acharya, D
24Acharya, P
25Adamu, Aa
26Adane, Aa
27Adebayo, Om
28Adedoyin, Ra
29Adekanmbi, V
30Ademi, Z
31Adetokunboh, O
32Adib, Mg
33Admasie, A
34Adsuar, Jc
35Afanvi, Ka
36Afarideh, M
37Agarwal, G
38Aggarwal, A
39Aghayan, Sa
40Agrawal, A
41Agrawal, S
42Ahmadi, A
43Ahmadi, M
44Ahmadieh, H
45Ahmed, Mb
46Aichour, An
47Aichour, I
48Aichour, Mte
49Akbari, Me
50Akinyemiju, T
51Akseer, N
52Al - Aly, Z
53Al - Eyadhy, A
54Al - Mekhlafi, Hm
55Alandab, F
56Alam, K
57Alam, S
58Alam, T
59Alashi, A
60Alavian, Sm
61Alene, Ka
62Ali, K
63Ali, Sm
64Alijanzadeh, M
65Alizadeh - Navaei, R
66Aljunid, Sm
67Alkerwi, A
68Alla, F
69Alsharif, U
70Altirkawi, K
71Alvis - Guzman, N
72Amare, At
73Ammar, W
74Anber, Nh
75Anderson, Ja
76Andrei, Cl
77Androudi, S
78Animut, Md
79Anjomshoa, M
80Ansha, Mg
81Anto, Jm
82Antonio, Cat
83Anwari, P
84Appiah, Lt
85Appiah, Scy
86Arabloo, J
87Aremu, O
88Amlov, J
89Artaman, A
90Aryal, Kk
91Asayesh, H
92Ataro, Z
93Ausloos, M
94Avokpaho, Efga
95Awasthi, A
96Quintanilla, Bpa
97Ayer, R
98Ayuk, Tb
99Azzopardi, Ps
100...
jtitleThe Lancet
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
aulast
0Stanaway
1Afshin
2Gakidou
3Lim
4Abate
5Abbafati
6Abbasi
7Abbastabar
8Abd-Allah
9Abdela
10Abdelalim
11Abdollahpour
12Abdulkader
13Abebe
14Abera
15Abil
16Abraha
17Abrham
18Abu-Raddad
19Abu-Rmeileh
20Accrombessi
21Acharya
22Adamu
23Adane
24Adebayo
25Adedoyin
26Adekanmbi
27Ademi
28Adetokunboh
29Adib
30Admasie
31Adsuar
32Afanvi
33Afarideh
34Agarwal
35Aggarwal
36Aghayan
37Agrawal
38Ahmadi
39Ahmadieh
40Ahmed
41Aichour
42Akbari
43Akinyemiju
44Akseer
45Al-Aly
46Al-Eyadhy
47Al-Mekhlafi
48Alandab
49Alam
50Alashi
51Alavian
52Alene
53Ali
54Alijanzadeh
55Alizadeh-Navaei
56Aljunid
57Alkerwi
58Alla
59Alsharif
60Altirkawi
61Alvis-Guzman
62Amare
63Ammar
64Anber
65Anderson
66Andrei
67Androudi
68Animut
69Anjomshoa
70Ansha
71Anto
72Antonio
73Anwari
74Appiah
75Arabloo
76Aremu
77Amlov
78Artaman
79Aryal
80Asayesh
81Ataro
82Ausloos
83Avokpaho
84Awasthi
85Quintanilla
86Ayer
87Ayuk
88Azzopardi
89Babazadeff
90Badali
91Badawi
92Balakrishnan
93Bali
94Ball
95Bellew
96Banach
97Banoub
98Barac
99Barker-Collo
100...
aufirst
0JD
1A
2E
3SS
4D
5KH
6C
7N
8H
9F
10J
11I
12RS
13M
14Z
15SF
16OZ
17HN
18AR
19LJ
20NME
21MMK
22P
23AA
24OM
25RA
26V
27O
28MG
29JC
30KA
31G
32SA
33S
34MB
35AN
36MTE
37ME
38T
39HM
40K
41SM
42R
43U
44AT
45W
46NH
47JA
48CL
49MD
50JM
51CAT
52LT
53SCY
54KK
55EFGA
56BPA
57TB
58PS
59AG
60SH
61JAM
62SL
63TW
64LH
65BT
66Y
67BB
68FT
69YA
70ML
71AK
72DA
73IM
74ZA
75B
76MS
77BF
78IR
79OJ
80NJK
81RT
82LE
83L
84JJ
85CA
86KM
87H-T
88J-C
89K-L
90FJ
91VK
92C-Y
93PP-C
94KL
95J-YJ
96DJ
97S-C
98FM
99AJ
100...
au
0Stanaway, Jd
1Afshin, A
2Gakidou, E
3Lim, Ss
4Abate, D
5Abate, Kh
6Abbafati, C
7Abbasi, N
8Abbastabar, H
9Abd - Allah, F
10Abdela, J
11Abdelalim, A
12Abdollahpour, I
13Abdulkader, Rs
14Abebe, M
15Abebe, Z
16Abera, Sf
17Abil, Oz
18Abraha, Hn
19Abrham, Ar
20Abu - Raddad, Lj
21Abu - Rmeileh, Nme
22Accrombessi, Mmk
23Acharya, D
24Acharya, P
25Adamu, Aa
26Adane, Aa
27Adebayo, Om
28Adedoyin, Ra
29Adekanmbi, V
30Ademi, Z
31Adetokunboh, O
32Adib, Mg
33Admasie, A
34Adsuar, Jc
35Afanvi, Ka
36Afarideh, M
37Agarwal, G
38Aggarwal, A
39Aghayan, Sa
40Agrawal, A
41Agrawal, S
42Ahmadi, A
43Ahmadi, M
44Ahmadieh, H
45Ahmed, Mb
46Aichour, An
47Aichour, I
48Aichour, Mte
49Akbari, Me
50Akinyemiju, T
51Akseer, N
52Al - Aly, Z
53Al - Eyadhy, A
54Al - Mekhlafi, Hm
55Alandab, F
56Alam, K
57Alam, S
58Alam, T
59Alashi, A
60Alavian, Sm
61Alene, Ka
62Ali, K
63Ali, Sm
64Alijanzadeh, M
65Alizadeh - Navaei, R
66Aljunid, Sm
67Alkerwi, A
68Alla, F
69Alsharif, U
70Altirkawi, K
71Alvis - Guzman, N
72Amare, At
73Ammar, W
74Anber, Nh
75Anderson, Ja
76Andrei, Cl
77Androudi, S
78Animut, Md
79Anjomshoa, M
80Ansha, Mg
81Anto, Jm
82Antonio, Cat
83Anwari, P
84Appiah, Lt
85Appiah, Scy
86Arabloo, J
87Aremu, O
88Amlov, J
89Artaman, A
90Aryal, Kk
91Asayesh, H
92Ataro, Z
93Ausloos, M
94Avokpaho, Efga
95Awasthi, A
96Quintanilla, Bpa
97Ayer, R
98Ayuk, Tb
99Azzopardi, Ps
100...
atitleGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
jtitleThe Lancet
risdate20181110
genrearticle
ristypeJOUR
abstractBackground: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associations. Methods: We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk–outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the risk-deleted death and DALY rates, where the risk-deleted rate is the rate that would be observed had we reduced the exposure levels to the TMREL for all risk factors included in GBD 2017. Findings: In 2017, 34·1 million (95% uncertainty interval [UI] 33·3–35·0) deaths and 1·21 billion (1·14–1·28) DALYs were attributable to GBD risk factors. Globally, 61·0% (59·6–62·4) of deaths and 48·3% (46·3–50·2) of DALYs were attributed to the GBD 2017 risk factors. When ranked by risk-attributable DALYs, high systolic blood pressure (SBP) was the leading risk factor, accounting for 10·4 million (9·39–11·5) deaths and 218 million (198–237) DALYs, followed by smoking (7·10 million [6·83–7·37] deaths and 182 million [173–193] DALYs), high fasting plasma glucose (6·53 million [5·23–8·23] deaths and 171 million [144–201] DALYs), high body-mass index (BMI; 4·72 million [2·99–6·70] deaths and 148 million [98·6–202] DALYs), and short gestation for birthweight (1·43 million [1·36–1·51] deaths and 139 million [131–147] DALYs). In total, risk-attributable DALYs declined by 4·9% (3·3–6·5) between 2007 and 2017. In the absence of demographic changes (ie, population growth and ageing), changes in risk exposure and risk-deleted DALYs would have led to a 23·5% decline in DALYs during that period. Conversely, in the absence of changes in risk exposure and risk-deleted DALYs, demographic changes would have led to an 18·6% increase in DALYs during that period. The ratios of observed risk exposure levels to exposure levels expected based on SDI (O/E ratios) increased globally for unsafe drinking water and household air pollution between 1990 and 2017. This result suggests that development is occurring more rapidly than are changes in the underlying risk structure in a population. Conversely, nearly universal declines in O/E ratios for smoking and alcohol use indicate that, for a given SDI, exposure to these risks is declining. In 2017, the leading Level 4 risk factor for age-standardised DALY rates was high SBP in four super-regions: central Europe, eastern Europe, and central Asia; north Africa and Middle East; south Asia; and southeast Asia, east Asia, and Oceania. The leading risk factor in the high-income super-region was smoking, in Latin America and Caribbean was high BMI, and in sub-Saharan Africa was unsafe sex. O/E ratios for unsafe sex in sub-Saharan Africa were notably high, and those for alcohol use in north Africa and the Middle East were notably low. Interpretation: By quantifying levels and trends in exposures to risk factors and the resulting disease burden, this assessment offers insight into where past policy and programme efforts might have been successful and highlights current priorities for public health action. Decreases in behavioural, environmental, and occupational risks have largely offset the effects of population growth and ageing, in relation to trends in absolute burden. Conversely, the combination of increasing metabolic risks and population ageing will probably continue to drive the increasing trends in non-communicable diseases at the global level, which presents both a public health challenge and opportunity. We see considerable spatiotemporal heterogeneity in levels of risk exposure and risk-attributable burden. Although levels of development underlie some of this heterogeneity, O/E ratios show risks for which countries are overperforming or underperforming relative to their level of development. As such, these ratios provide a benchmarking tool to help to focus local decision making. Our findings reinforce the importance of both risk exposure monitoring and epidemiological research to assess causal connections between risks and health outcomes, and they highlight the usefulness of the GBD study in synthesising data to draw comprehensive and robust conclusions that help to inform good policy and strategic health planning.
pubELSEVIER SCIENCE INC
urlhttp://discovery.ucl.ac.uk/10063523/1/Global%20Burden%20of%20Disease%20_s2.0-S0140673618322256-main.pdf
formatarticle
oafree_for_read
date2018-11-10